PurpleLab

PurpleLab announces Series B funding round led by Primus Capital Funds (Primus Capital), joining existing investor Edison Partners. The investment highlights PurpleLab’s growing role in simplifying the access to and interpretation of Real-World Data across the healthcare continuum. https://bit.ly/3RJrYio #RWD

Looking to improve diversity, equity, and inclusion in your #clinicaltrials? Check out Pharmacy Podcast Network's latest episode featuring #PurpleLab, and hear how Russell Robbins and Jason Gagner MBA, MS delve into the critical topic of achieving more representative and equitable clinical trials through a data-driven approach. Real-world data is a must for clinical researchers who want to ensure their trials are inclusive and reach the populations who need them most, and remain compliant with the FDA’s DEI guidance. #clinicaltrials #diversity #inclusion #datadriven #pharmacy #research #dei 🎙 https://lnkd.in/dhf_3g6b

Do you feel it’s survival of the fittest in the healthcare marketing industry nowadays? You’re not wrong! In order to come out victorious, strategic audience development is crucial. Marketers must navigate the complexities around healthcare providers' needs, digital engagement, and data insights to craft even more effective campaigns. In our latest whitepaper, we take a stroll down memory lane to better understand the history of pharmaceutical marketing and map out how to build precise, targeted audiences in today’s overcrowded marketplace. The precision of data-driven strategies is unparalleled. 😎 🔗 https://lnkd.in/eGCaFU2Y

We’re putting our data to work! 💪 We dug into our HealthNexus database, one of the largest US pharma and medical claims databases, to work with Bloomberg on another story surrounding GLP1s in the States. Surprisingly enough, our data showed that Kentucky is the weight-loss drug capital of the United States. 📈 Some interesting findings showed that at least 4% of Bowling Green residents have received #Ozempic or similar prescriptions in the past year. Kentucky's high obesity rates, employer insurance coverage, and the city's middle-class demographics are key indicators of why there’s a higher adoption than in other “weight loss crazed” cities like Los Angeles or New York. Shout out to our Chief Medical Information Officer, Russell Robbins, for looking into our data, and Tanaz Meghjani from Bloomberg News for working together with us. 👉 https://lnkd.in/d3Tbaw5G #PurpleLab #WeightLoss #ClinicalTrials #DiversityInClinicalTrials #Kentucky

Deerfield Group, a leading medical and pharmaceutical marketing agency, partnered with us to harness the power of real-world data (RWD) through our Prescription Measurement Report. 📊 Our collaboration allowed Deerfield to transform its approach to healthcare marketing by providing hyper-personalized campaigns and precise targeting. In this case study, you can see how Deerfield: 🎯 Identified key healthcare providers and facilities, optimizing targeting for a bladder cancer client. 📍Developed data-driven, region-specific marketing plans based on seasonal variations in eczema prescriptions. ❗Enhanced promotional strategies by quickly mapping the porphyria diagnosis landscape and addressing external factors affecting drug performance. Leveraging PurpleLab’s Prescription Measurement report, Deerfield unlocked valuable insights, streamlining its marketing strategies and delivering even greater value to its clients. 👉 Check out the full case study in the comments below! #CaseStudy #HealthcareAnalytics #PurpleLab #RealWorldData

Can't wait to see you tomorrow! 📅 Join us and discover: ✅ How to design effective, data-backed clinical protocols. ✅ Tips for assessing trial feasibility with precision. ✅ Ways to utilize targeted strategies for efficient patient enrollment. ✅ A guide on implementing robust retention strategies to maintain study integrity. ✅ Why choosing the right partner for actionable insights is key to turning around struggling trials. Register here 👉 https://lnkd.in/dtptRY_S. Shannon LaRusso Jason Gagner MBA, MS #ClinicalTrials #RealWorldData #HealthcareAnalytics #HealthData

Pharmaceutical manufacturers do more than just produce medications; they also need to respond to market conditions, clinical guidelines, and safety regulations to meet patient needs. Real-world evidence (RWE) offers valuable insights into patient healthcare, including treatment utilization and outcomes 👇 💊 While developing new drugs and medications, RWE helps gain insights into disease prevalence and treatment pathways and design more efficient clinical trials. 🤝 It aids applications for new drug indications and approvals. 🔎 It helps continuously assess drug safety, effectiveness, and cost-effectiveness after initial trials and approvals. 🛑 Yet, RWE data can vary in quality and lack the robustness of clinical trials, so it’s essential to complement it with controlled trial data, and incorporate it into pharmaceutical manufacturing processes to enhance decision-making across the drug lifecycle. 👉 Read more about RWE's impact on pharma manufacturing here: https://lnkd.in/ewzY6CRA  #RealWorldEvidence #PurpleLab #HealthData #HealthcareAnalytics

Pharma brands face challenges with TV ad targeting and measurement due to stringent patient data regulations like HIPAA and the My Health My Data Act. 😵💫 Even if access to patient data were easier, targeting ads based on health conditions can feel invasive to consumers. Recently Datavant partnered with Blockgraph to tackle this issue. Now, TV buyers and sellers can match insurance claims data, which we provide to Datavant, with TV ad exposure data, which Blockgraph gets from the TV distributors and publishers it’s integrated with. Blockgraph is jointly owned by Comcast, Charter and Paramount. Providing deidentified claims data to enhance TV ad measurement for pharma brands while ensuring consumer privacy? Count 👏us 👏in! 🔗 Read more in the comments below! Jason Manningham Scott Ronay #PharmaMarketing #TVAdvertising #DataPrivacy #HealthData #AdTech

📆SAVE THE DATE: August 21 at 12:00 PM ET we’re partnering with Fierce Pharma on a webinar on how to leverage data to maximize clinical trial success. Join us to learn more about how data-driven strategies can transform the clinical trial process from start to finish. Discover the latest tools and insights to optimize every phase of your trials, whether you're starting a new study or enhancing ongoing ones. Speakers: 🎙️ Shannon LaRusso - SVP of Product Management, PurpleLab 🎙️ Jason Gagner MBA, MS - VP of Product Management, Life Sciences, PurpleLab Register now on the link in the comments! 👇 #ClinicalTrials #DataDriven #HealthcareInnovation #LifeSciences #PurpleLab 

We're on a mission to help healthcare organizations tackle medication adherence using robust real-world data (RWD) and real-world evidence (RWE). 📊 RWE provides valuable insights into medication use and adherence, helping us understand what works in the real world. 🏥 Poor medication adherence results in 125,000 deaths annually and costs the healthcare system billions. It's a major issue leading to more hospital visits and delayed treatments. 🔍Health plans can use RWE to spot and support members at risk of not taking their medications. By integrating diverse data sources, we can develop better intervention strategies. 🌐 Access to open claims data gives a fuller picture of a member's health over time, even if they switch plans. This comprehensive view is crucial for managing chronic diseases effectively and identifying trends and issues that need attention. Let us help fill your data gaps. Enhance your planning, boost medication adherence, and cut care costs. #Healthcare #MedicationAdherence #RealWorldEvidence #PurpleLab #HealthData #HealthPlans #DataAnalytics